Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

709
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
709
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

1.7K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.7K
Hypertension I: Introduction01:28

Hypertension I: Introduction

1.2K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.4K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

824
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
824
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

45S5 bioglass graft decreases surgical site infection after posterior transforaminal lumbar interbody fusion reconstruction compared to alternative graft materials.

Journal of spine surgery (Hong Kong)·2026
Same author

RNAScope-Ancestry: A Cross-Modality Framework for Inferring Genetic Ancestry from RNA-Seq with Application to MECA.

Research square·2026
Same author

The Relationship Between Forms of Childhood Maltreatment and Vascular Function Indices in Black Men and Women.

Biopsychosocial science and medicine·2025
Same author

<i>ADCY3</i> Ser107Pro links difficulty awakening in the morning to adiposity through circadian regulation of adipose thermogenesis.

bioRxiv : the preprint server for biology·2025
Same author

An integrative approach prioritizes the orphan GPR61 genomic region in tissue-specific regulation of chronotype.

Sleep advances : a journal of the Sleep Research Society·2025
Same author

Biological Age as a Predictor of Arterial Stiffness in Young and Early Midlife Black and White Women.

American journal of hypertension·2025

Related Experiment Video

Updated: Mar 21, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Machine Learning Data Imputation and Classification in a Multicohort Hypertension Clinical Study.

William Seffens1, Chad Evans1,

  • 1Physiology Department, Morehouse School of Medicine, Atlanta, GA, USA.

Bioinformatics and Biology Insights
|May 21, 2016
PubMed
Summary

Machine learning improved hypertension research by imputing missing data in African American participants. This enhanced dataset revealed new associations between traits and hypertension risk.

Keywords:
artificial neural networkdata imputationhypertensionmachine learning

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Related Experiment Videos

Last Updated: Mar 21, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Area of Science:

  • Genomics
  • Translational Research
  • Medical Informatics

Background:

  • Healthcare initiatives promote clinical data use for medical discovery.
  • Machine learning (ML) aids in detecting patterns in complex diseases like hypertension.
  • Previous genomic studies in African Americans (AA) focused on rare variants for hypertension, yielding limited results.

Purpose of the Study:

  • To apply ML for analyzing phenotype data in African American (AA) participants within the Minority Health Genomics and Translational Research Repository Database.
  • To impute missing phenotype data using neural networks to expand the usable clinical dataset.
  • To validate the expanded dataset's utility for identifying associations between phenotype variables and hypertension case/control status.

Main Methods:

  • Utilized neural networks for phenotype data imputation to address missing values.
  • Expanded the clinical dataset size through data imputation.
  • Employed data mining classification tools to generate association rules.

Main Results:

  • The expanded dataset, created by ML imputation, demonstrated improved performance in associating phenotype variables with hypertension status.
  • Association rules were successfully generated using data mining techniques.
  • The study highlights the effectiveness of ML in uncovering complex relationships in genomic and clinical data.

Conclusions:

  • Machine learning imputation is effective for increasing the usability of clinical datasets for hypertension research in African American populations.
  • This approach can uncover novel associations between phenotype and genotype data, advancing translational research.
  • The findings support the use of advanced statistical methods for complex disease research in diverse populations.